Merriman Curhan Ford downgrades Ligand Pharmaceuticals Inc. (Nasdaq: LGND) from Buy to Neutral, saying the company has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE